Back to Journals » Drug, Healthcare and Patient Safety » Volume 7

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Total article views   Abstract views HTML views PDF downloads Totals
10,274 Dovepress* 8,976 704+ 588 9,680
PubMed Central* 0 594 194 594
Totals 8,976 1,298 782 10,274
*Since 15 December 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 0 0 0 8 10

View citations on PubMed Central and Google Scholar